<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12</volume><submitter>Gupta CL</submitter><pubmed_abstract>Emergence of the drug resistant variants of the Influenza A virus in the recent years has aroused a great need for the development of novel neuraminidase inhibitors for controlling the pandemic. The neuraminidase (NA) protein of the influenza virus has been the most potential target for the anti-influenza. However, in the absence of any experimental structure of the drug targeting NA protein of H1N1 influenza A virus as zanamivir and oseltamivir, the comprehensive study of the interaction of the drug molecules with the target protein has been missing. Hence in this study a computational 3-D structure of neuraminidase of H1N1 influenza A virus has been developed using homology modeling technique, and the same was validated for its reliability by ProSA web server in term of energy profile &amp; </pubmed_abstract><journal>EXCLI journal</journal><pagination>215-25</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4556016</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Computational modeling and validation studies of 3-D structure of neuraminidase protein of H1N1 influenza A virus and subsequent in silico elucidation of piceid analogues as its potent inhibitors.</pubmed_title><pmcid>PMC4556016</pmcid><pubmed_authors>Gupta CL</pubmed_authors><pubmed_authors>Akhtar S</pubmed_authors><pubmed_authors>Tiwari AK</pubmed_authors><pubmed_authors>Bajpaib P</pubmed_authors><pubmed_authors>Desai GS</pubmed_authors><pubmed_authors>Kandpal KN</pubmed_authors></additional><is_claimable>false</is_claimable><name>Computational modeling and validation studies of 3-D structure of neuraminidase protein of H1N1 influenza A virus and subsequent in silico elucidation of piceid analogues as its potent inhibitors.</name><description>Emergence of the drug resistant variants of the Influenza A virus in the recent years has aroused a great need for the development of novel neuraminidase inhibitors for controlling the pandemic. The neuraminidase (NA) protein of the influenza virus has been the most potential target for the anti-influenza. However, in the absence of any experimental structure of the drug targeting NA protein of H1N1 influenza A virus as zanamivir and oseltamivir, the comprehensive study of the interaction of the drug molecules with the target protein has been missing. Hence in this study a computational 3-D structure of neuraminidase of H1N1 influenza A virus has been developed using homology modeling technique, and the same was validated for its reliability by ProSA web server in term of energy profile &amp; </description><dates><release>2013-01-01T00:00:00Z</release><publication>2013</publication><modification>2026-05-30T04:16:34.451Z</modification><creation>2019-03-27T01:57:36Z</creation></dates><accession>S-EPMC4556016</accession><cross_references><pubmed>26417228</pubmed></cross_references></HashMap>